BRCA2 and ovarian serous adenocarcinoma: The term “pelvic serous cancer” is used because the majority of BRCA1- and BRCA2-related gynaecologic cancers appear to originate in the fimbrial end of the fallopian tube rather than the ovary, although they have typically been labelled as “serous ovarian cancer” at diagnosis [6].